EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

What Is the Best Risk-Reducing Decision for Breast Cancer Patients With BRCA1/2 Mutation?

Elmira Ebrahimi, Reza Shirkoohi

Archives of Breast Cancer · 2018

DOI: 10.32768/abc.201854148-149 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Breast Cancer, 2018. Verfasst von Elmira Ebrahimi und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

N/A

Zitieren

APA

Ebrahimi, E., & Shirkoohi, R. (2018). What Is the Best Risk-Reducing Decision for Breast Cancer Patients With BRCA1/2 Mutation?. Archives of Breast Cancer. https://doi.org/10.32768/abc.201854148-149

Vancouver

Ebrahimi E, Shirkoohi R. What Is the Best Risk-Reducing Decision for Breast Cancer Patients With BRCA1/2 Mutation?. Archives of Breast Cancer. 2018. doi:10.32768/abc.201854148-149

BibTeX
@article{Ebrahimi2018,
  author = {Ebrahimi, Elmira and Shirkoohi, Reza},
  title = {What Is the Best Risk-Reducing Decision for Breast Cancer Patients With BRCA1/2 Mutation?},
  journal = {Archives of Breast Cancer},
  year = {2018},
  doi = {10.32768/abc.201854148-149}
}
Kostenlos starten →